Development of Potent Purine-Derived Nitrile Inhibitors of the Trypanosomal Protease TbcatB
Posted on 2008-02-14 - 00:00
Human African trypanosomiasis (HAT), a major health concern in sub-Saharan Africa, is caused by the protozoan parasite Trypanosoma brucei. Recent studies have shown that a cathepsin B like protease, TbcatB, is essential to the survival of T. brucei in vitro (Mackey, Z. B.; O'Brien, T. C.; Greenbaum, D. C.; Blank, R. B.; McKerrow, J. H. J. Biol. Chem. 2004, 279, 48426−48433). Herein, we describe the first inhibitors of TbcatB, a series of purine nitriles. The compounds are potent trypanocides, killing the parasite with a high degree of selectivity over a panel of three human cell lines. In addition, a predictive model of trypanocidal activity was developed on the basis of potency against TbcatB and various calculated physical property descriptors.
CITE THIS COLLECTION
DataCiteDataCite
No result found
Mallari, Jeremy P.; Shelat, Anang A.; Obrien, Terri; Caffrey, Conor R.; Kosinski, Aaron; Connelly, Michele; et al. (2016). Development of Potent Purine-Derived Nitrile Inhibitors of the Trypanosomal Protease TbcatB. ACS Publications. Collection. https://doi.org/10.1021/jm070760l